Identification of a new protein biomarker for colorectal cancer diagnosis

Molecular Medicine Reports

Volumn 6, Issue 2, 2012, Pages 444-448

  Zhai, Xiao Hui ^a   Yu, Jie Kai ^a   Yang, Fu Quan ^b   Zheng, Shu ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Biomarker; Colorectal cancer; Identification; Proteomics

Indexed keywords

PROTEIN; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE 4; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN BLOOD LEVEL; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY;

ADULT; AGED; AMINO ACID SEQUENCE; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NEOPLASM STAGING; PEPTIDE FRAGMENTS; PROTEIN-SERINE-THREONINE KINASES; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84863451265     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.923     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Yu ZJ, Zhi JL, Peng XF, Zhong XH and Xu AG: Clinical significance of HSP27 expression in colorectal cancer. Mol Med Report 3: 953-958, 2010.
3. Jemal A, Siegel R, Ward E, Hao YP, Xu JQ and Thun MJ: Cancer statistics. CA Cancer J Clin 59: 225-249, 2009.
4. Ohsawa T, Sahara T, Muramatsu S, Nishimura Y, Yathuoka T, Tanaka Y, Yamaguchi K, Ishida H and Akagi K: Colorectal cancer s usceptibility a ssociated w ith t he HMLH1 V384D variant. Mol Med Report 2: 887-891, 2009.
5. Poston GJ, Tait D, O'Connell S, Bennett A and Berendse S: Guidelines diagnosis and management of colorectal cancer: summary of NICE guidance. BMJ: doi: 10.1136/bmj.d6751.
6. Lisi D, Hassan CC and Crespi M; AMOD Study Group: Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study. Dig Liver Dis 42: 371-376, 2010.
7. Basbug M, Arikanoglu Z, Bulbuller N, Cetinkaya Z, Aygen E, Akbulut S and Satici O: Prognostic value of preoperative CEA and CA 19-9 levels in patients with colorectal cancer. Hepatogastroenterology 58: 400-405, 2011.
8. Dihlmann W: Economical and standardized double contrast radiography of the colon in adults. Deut Med Wochenschr 105: 1138-1141, 1980.
9. Choi Y, Choi HS, Jeon WK, Kim BI, Park DI, Cho YK, Kim HJ, Park JH and Sohn CI: Optimal number of endoscopic biopsies in diagnosis of advanced gastric and colorectal cancer. J Korean Med Sci 27: 36-39, 2012.
10. Hong YJ, Wang XD, Shen D and Zeng S: Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection. Acta Pharmacol Sin 29: 1240-1246, 2008.
11. Liu C, Shen J, Pan C, Yang L, Mou S, Wang H and Liang Y: MALDI-TOF-MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of hepatocellular carcinoma. Am J Clin Pathol 134: 235-241, 2010.
12. Yu JK, Chen YD and Zheng S: An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics. World J Gastroenterol 10: 3127-3131, 2004.
13. Hu Y, Zhang SZ, Yu JK, Liu J and Zheng S: SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer. Breast 14: 250-255, 2005. (Pubitemid 41110184)
14. Wang JX, Yu JK, Wang L, Liu QL, Zhang J and Zheng S: Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma. Proteomics 6: 5344-5349, 2006. (Pubitemid 44547171)
15. Zheng N, Pan C and Liu W: New serum biomarkers for detection of endometriosis using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Int Med Res 39: 1184-1192, 2011.
16. Guo RY, Pan CQ, Shen JM and Liu CB: New serum biomarkers for detection of esophageal carcinoma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Cancer Res Clin Oncol 137: 513-519, 2011.
17. Raeisossadati R, Farshchian M, Ganji A, Tavassoli A, Velayati A, Dadkhah E, Chavoshi S, Mehrabi Bahar M, Memar B, Rajabi Mashhadi MT, et al: Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients. Int J Colorectal Dis 26: 1265-1270, 2011.
18. Ial'chenko NA, Lagutin VD, Lavik NN and Musin II: The clinical-value of immunoenzyme assay of CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum. Vopr Onkol 37: 921-924, 1991 (in Russian).
19. Marengo E, Robotti E, Bobba M, Milli A, Campostrini N, Righetti SC, Cecconi D and Righetti PG: Application of partial least squares discriminant analysis and variable selection procedures: a 2D-PAGE proteomic study. Anal Bioanal Chem 390: 1327-1342, 2008.
20. Deng BP, Dong ZG, Liu YG, Wang C, Liu J, Wang C and Qu X: Effects of pretreatment protocols on human amniotic fluid protein profiling with SELDI-TOF-MS using protein chips and magnetic beads. Clin Chim Acta 411: 1051-1057, 2010.
21. Shi CY, Meng JR and Deng CH: Enrichment and detection of small molecules using magnetic graphene as an adsorbent and a novel matrix of MALDI-TOF-MS. Chem Commun (Camb) 48: 2418-2420, 2012.
22. Ge Z, Zhu YL, Zhong X, Yu JK and Zheng S: Discovering differential protein expression caused by caga-induced ERK pathway activation in AGS cells using the SELDI-ProteinChip platform. World J Gastroenterol 14: 554-562, 2008. (Pubitemid 351320821)
23. Han MY, Liu Q, Yu JK and Zheng S: Detection and significance of serum protein markers of small-cell lung cancer. J Clin Lab Anal 22: 131-137, 2008. (Pubitemid 351543945)
24. Dridi B, Raoult D and Drancourt M: Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identification of archaea: towards the universal identification of living organisms. APMIS 120: 85-91, 2012.
25. Liu YP, Liu P, Dai RY, Wang J, Zheng Y, Shen J, Guo F, Wang L, Li H and Wei M: Analysis of plasma proteome from cases of the different traditional Chinese medicine syndromes in patients with chronic hepatitis B. J Pharm Biomed Anal 59: 173-178, 2012.
26. Cheung WL, Ajiro K, Samejima K, Kloc M, Cheung P, Mizzen CA, Beeser A, Etkin LD, Chernoff J, Earnshaw WC and Allis CD: Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 113: 507-517, 2003. (Pubitemid 36603322)
27. Babel I, Barderas R, Diaz-Uriarte R, Martinez-Torrecuadrada JL, Sánchez-Carbayo M and Casal JI: Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol Cell Proteomics 8: 2382-2395, 2009.
28. Babel I, Barderas R, Diaz-Uriarte R, Moreno V, Suarez A, Fernandez-Aceñero MJ, Salazar R, Capellá G and Casal JI: Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays. Mol Cell Proteomics 10: M110.001784, 2011.
29. Adams H, Tzankov A, Lugli A and Zlobec I: New time-dependent approach to analyse the prognostic significance of immunohistochemical biomarkers in colon cancer and diffuse large B-cell lymphoma. J Clin Pathol 62: 986-997, 2009.